Literature DB >> 7657542

HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus.

H B Qavi1, M T Green, D E Lewis, F B Hollinger, G Pearson, D V Ablashi.   

Abstract

PURPOSE: The purpose of this study was to define the agents involved in the development of acquired immune deficiency syndrome (AIDS)-associated retinitis. To achieve this goal, the authors determined the frequency and proximity of the simultaneous presence of human immunodeficiency virus (HIV)-1, human herpesvirus (HHV)-6, and human cytomegalovirus (HCMV) in retinas of patients with AIDS with and without AIDS-associated retinitis.
METHODS: Retinal sections from 50 globes from patients with AIDS were analyzed for the presence of viral antigens and transcripts. Group 1 contained 13 globes from patients with HCMV infection. Group 2 contained 20 globes from patients with retinal lesions of uncertain etiology in which HCMV antigen and transcripts were not detected. Group 3 contained 17 globes from patients with no retinal lesions.
RESULTS: Retinal sections from all 13 globes (group 1) were positive for HCMV antigens and HIV-1 antigens and transcripts. Six of the 13 retinas were also positive for HHV-6 antigens and transcripts. Sections from 13 of the 20 globes (group 2) were positive for HIV-1 antigens and transcripts, and 5 of these 13 were also positive for HHV-6 antigens and transcripts. Multiple areas in sections from two of the HIV-1-positive retinas showed coinfection with HHV-6. All 17 globes (group 3) were positive for HIV-1 antigens and transcripts. Ten of these 17 retinas were also positive for HHV-6 antigens. Human cytomegalovirus antigens were not detectable in retinas from groups 2 and 3. No viral antigens or transcripts were detectable in retinal sections from 10 HIV-1 negative donors.
CONCLUSION: The coexistence of HIV-1 and HHV-6 activity in more than 50% of retinas without HCMV infection suggests that HIV-1 and HHV-6 alone or in combination may predispose retinal tissue to other opportunistic agents such as HCMV during the development of AIDS-associated retinitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657542

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR.

Authors:  Nahoko Ogata; Naoko Koike; Tadanobu Yoshikawa; Kanji Takahashi
Journal:  Jpn J Ophthalmol       Date:  2011-08-04       Impact factor: 2.447

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Human herpesvirus 6-A, 6-B, and 7 in vitreous fluid samples.

Authors:  Jeffrey I Cohen; Gary Fahle; Margaret A Kemp; Kathleen Apakupakul; Todd P Margolis
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

5.  Bilateral optic neuropathy and unilateral tonic pupil associated with acute human herpesvirus 6 infection: a case report.

Authors:  Isabel M Oberacher-Velten; Jost B Jonas; Anselm Jünemann; Barbara Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-10       Impact factor: 3.117

6.  Age-Related Macular Degeneration: A Connection between Human Herpes Virus-6A-Induced CD46 Downregulation and Complement Activation?

Authors:  Walter Fierz
Journal:  Front Immunol       Date:  2017-10-17       Impact factor: 7.561

7.  EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.

Authors:  Lassina Traore; Ouéogo Nikiema; Abdoul Karim Ouattara; Tegwindé Rébéca Compaore; Serge Théophile Soubeiga; Birama Diarra; Dorcas Obiri-Yeboah; Pegdwendé Abel Sorgho; Florencia Wendkuuni Djigma; Cyrille Bisseye; Albert Théophane Yonli; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.